In addition to the histological liver parameters, the NAFLD group displayed significantly higher body weight, BMI, fasting plasma glucose, serum insulin, C‐peptide, triglycerides, ALT, and ALP than the non‐NAFLD group. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.